2seventy bio Inc (NASDAQ: TSVT) is 17.33% higher on its value in year-to-date trading and has touched a low of $1.53 and a high of $6.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TSVT stock was last observed hovering at around $4.95 in the last trading session, with the day’s gains setting it 0.06%.
Currently trading at $5.01, the stock is 3.04% and 5.24% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing 1.21% at the moment leaves the stock 6.90% off its SMA200. TSVT registered 97.24% gain for a year compared to 6-month gain of 12.97%. The firm has a 50-day simple moving average (SMA 50) of $4.749 and a 200-day simple moving average (SMA200) of $4.677025.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.66% loss in the last 1 month and extending the period to 3 months gives it a 19.86%, and is 15.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.86% over the week and 4.58% over the month.
2seventy bio Inc (TSVT) has around 274 employees, a market worth around $258.00M and $44.12M in sales. Profit margin for the company is -354.16%. Distance from 52-week low is 226.38% and -21.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.20%).
The EPS is expected to grow by 83.05% this year
158.0 institutions hold shares in 2seventy bio Inc (TSVT), with institutional investors hold 99.67% of the company’s shares. The shares outstanding are 50.63M, and float is at 48.21M with Short Float at 11.24%. Institutions hold 95.61% of the Float.
The top institutional shareholder in the company is KYNAM CAPITAL MANAGEMENT, LP with over 5.95 million shares valued at $22.92 million. The investor’s holdings represent 11.4341 of the TSVT Shares outstanding. As of 2024-06-30, the second largest holder is GOLDMAN SACHS GROUP INC with 4.14 million shares valued at $15.93 million to account for 7.9465 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.66 million shares representing 7.0308 and valued at over $14.09 million, while VANGUARD GROUP INC holds 6.9696 of the shares totaling 3.63 million with a market value of $13.97 million.
2seventy bio Inc (TSVT) Insider Activity
The most recent transaction is an insider sale by Snow Jessica, the company’s. SEC filings show that Snow Jessica sold 7,816 shares of the company’s common stock on Aug 14 ’24 at a price of $4.32 per share for a total of $33760.0. Following the sale, the insider now owns 0.16 million shares.
Still, SEC filings show that on Aug 05 ’24, Eatwell Victoria (Chief Financial Officer) disposed off 13 shares at an average price of $3.98 for $52.0. The insider now directly holds 341,319 shares of 2seventy bio Inc (TSVT).
